| Pages:
1
2
3 |
Texium
Administrator
Posts: 4580
Registered: 11-1-2014
Location: Salt Lake City
Member Is Offline
Mood: PhD candidate!
|
|
Quote: Originally posted by WGTR  | | I wonder if you have already had the illness, if you get the vaccine are you more likely to get side effects? Like anything else, I imagine that the
answer is, “it depends”. |
I have read that that is a likely trend, and it is backed up by the anecdotes
that I have heard. People I know who had covid have all seemed to have the more unpleasant side effects while those who didn't have been fine.
I am curious to see how I fare with the vaccine (I am scheduled for next week, though I don't know yet which one I'll be getting). Early last March I
was sick for a few days after coming home from visiting Utah for a recruitment weekend. It was before mask-wearing was widely accepted, and it wasn't
even known to the public at that time that the virus was already spreading in the US. Thus I had flown on a plane, and gone to restaurants and bars
with virtually no precautions taken. Since testing wasn't available yet at that time, I have no idea whether I had it or if it was just a common cold.
|
|
|
pantone159
National Hazard
Posts: 590
Registered: 27-6-2006
Location: Austin, TX, USA
Member Is Offline
Mood: desperate for shade
|
|
I got my second Pfizer shot last Thursday. For both, I had a sore arm and felt a little off for a day or so, but nothing that stopped me from doing
anything. I now have both an old and new school vaccine card, first the Yellow Card for yellow fever (which has been required for some international
travel for a long time), and now the new USA CDC COVID card (not necessarily accepted internationally).
It is very nice to have a fixed date on the calendar when I can treat life normally. I just had a campout with a big group of friends, we had not seen
many of them in person for the past year, and most everybody had at least partial vaccination, and with being outdoors, it was possible to act normal
again in a group for the first time since last March. It will be good to wear masks indoors until everybody has a chance to get the shot, to set a
good example if nothing else, but I am used to that part now.
|
|
|
Elemental Phosphorus
Hazard to Others
Posts: 185
Registered: 11-11-2016
Location: Is everything
Member Is Offline
Mood: No Mood
|
|
While this is only tangentially related, one thing that worries me about current vaccines is the focus on the spike protein, because when the spike
protein mutates, the vaccines may be less effective. As I understand it, the mRNA sequence in Pfizer and Moderna vaccines codes for the coronavirus
spike protein, and then the immune system learns to recognize it. The viral vector vaccines like J&J and Sputnik V also seem to code for the spike
protein, but using an adenovirus to deliver that genetic code instead.
Most vaccines have reported a significantly reduced efficacy against the B.1.351 variant (South African variant), most likely because antibodies that
are made to bind the original 'wild type' spike protein are less effective at binding these mutated spike proteins.
AstraZeneca reported much lower efficacy against the variant, J&J reported efficacy of 57% as opposed to 72% against wild type virus, Novavax
reported 60% against B.1.351 as opposed to 96% against wild type. In a 'in vitro' trial, Pfizer reported antibodies as having about 10x less
neutralizing activity against B.1.351, although their human trial in South Africa so far seems to be reporting positive results.
It seems like some scientists think that because of the focus on antibody production against the spike protein, even a minor change in the spike
decreases antibody neutralizing activity, and these vaccines (mRNA vaccines and viral vector vaccines that code for the spike, and the Novavax vaccine
which contains spike proteins attached to nanoparticles) tend to focus on teaching the immune system to recognize and destroy the spike protein rather
than other parts of the virus or the virus as a whole, and this approach gives lots of antibodies (which seem to protect pretty well) and relatively
less of a response from T cells and other immune cells. This worries me a bit since antibody neutralizing activity seems to decrease significantly
against certain variants of Covid-19 but apparently T cells still recognize all of the variants quite well (https://www.reuters.com/article/idUSKBN2BM3B1)
All of the vaccines still seem to be quite good at preventing hospitalization and death, even from the variants, but I would worry that eventually a
variant may emerge which escapes immune protection more thoroughly, because all of the vaccines available in the West currently seem to target the
spike protein.
One piece of good news though, is that the inactivated virus vaccine made by Sinopharm appears to retain pretty good efficacy against the B.1.351
variant in vitro, they claim that neutralizing activity only decreased by 1.6 times in a study:
https://www.biorxiv.org/content/10.1101/2021.02.01.429069v1....
Also good news, is that possibly more vaccines are being developed for COVID-19 than for any other disease ever (except maybe the flu?) and other
vaccines which claim to be able to induce better immunity against parts of the virus other than just the spike are in the pipeline, some are using
viral vectors that code for multiple pieces of the virus, some are directly injecting other viral proteins, etc.
One vaccine that interested me was this one that contains 11 different viral proteins that are apparently less likely to mutate (I don't know enough
about virology to comment on that) and supposedly produces good T cell responses as well:
https://www.biospace.com/article/releases/ose-immunotherapeu...
The Pasteur institute and a company called TheraVectys are developing a nasal spray viral vector vaccine, rationale being that since the SARS-CoV-2
virus tends to infect through the respiratory tract, the best place to produce an immune response would be the respiratory tract. They claim that it
was almost completely protective in monkeys, so that's another exciting development. The press release is here, if anyone is interested:
https://www.pasteur.fr/en/all-sars-cov-2-covid-19-institut-p...
On an unrelated note, I received my first shot recently (Pfizer). I am pretty young, but I got a message saying that I was eligible (I had previously
pre-registered) so I went ahead and got it. Noticed no ill effects other than a sore arm and maybe a little tiredness, but it could have been because
I was not sleeping well.
Sharp contrast with a meningitis vaccine that I received about a month ago, which had my arm extremely sore for most of a week, and gave me about a
day and a half of fever and chills. I guess a lot of it is up to chance.
I wonder if the risk of a live attenuated virus vaccine (which usually tend to produce a robust T cell and good all-around immune response) would be
low enough in already-vaccinated people to justify the slight risk of an infection.
|
|
|
MadHatter
International Hazard
Posts: 1339
Registered: 9-7-2004
Location: Maine
Member Is Offline
Mood: Enjoying retirement
|
|
Pfizer Covid-19 Vaccine
3 days after my 2nd shot and no ill effects.
Even my shoulder stopped hurting. 
From opening of NCIS New Orleans - It goes a BOOM ! BOOM ! BOOM ! MUHAHAHAHAHAHAHA !
|
|
|
zed
International Hazard
Posts: 2283
Registered: 6-9-2008
Location: Great State of Jefferson, City of Portland
Member Is Offline
Mood: Semi-repentant Sith Lord
|
|
Well, I slept and slept, after my vaccination. Wasn't really tired or anything. Just felt good to sleep.
I just felt relaxed and good. De-stressed. Sleeping from relief?
I'm expecting to need some boosters bye and bye.
Perhaps we were lucky that this pandemic has been relatively mild.
As terrible as it has been; it could have been a lot worse.
Good preparation for the next one. A learning experience.
I've learned a lot about protective gear. Not to mention, keeping some food in reserve.
|
|
|
| Pages:
1
2
3 |
|
![[*]](images/xpblue/default_icon.gif){kind=icon}
